市場調査レポート

商品コード

1747566

分子イメージング市場：製品種類別、ソフトウェアプラットフォーム別、用途別、エンドユーザー別、地域別

Molecular Imaging Market, By Product Type, Software Platforms, By Application, By End User, By Geography

出版日: 2025年05月05日
発行: Coherent Market Insights
ページ情報: 英文 180 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 658,620円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,024,520円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,463,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.36円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の分子イメージング市場は、2025年に53億2,000万米ドルと推定され、2032年には77億9,000万米ドルに達すると予測され、2025年から2032年までのCAGRは5.6%です。

分析範囲		分析詳細
基準年	2024年	市場規模 (2025年)	53億2,000万米ドル
実績データ	2020～2024年	予測期間	2025～2032年
予測期間のCAGR (2025～2032年)	5.60%	予測金額 (2032年)	77億9,000万米ドル

分子イメージングとは、医療用イメージングの一分野であり、生きている患者の医療上の関心分子をイメージングすることに焦点を当てています。分子イメージング技術は、分子生物学と細胞生物学を統合した高度なイメージング技術です。安全で、非侵襲的で、痛みを伴わない治療法であり、心臓血管、神経、腫瘍、呼吸器、消化器など幅広い疾患の診断と管理に用いられます。分子イメージングは核医学の一分野です。少量の放射性物質（放射性医薬品）を用いて病気の診断や治療を行う。さらに、分子イメージングは、医師が病気を管理し、患者のケアを個別化するのに役立ちます。

市場力学

分子イメージング法は、様々な種類のがんに対する標準治療の一部となっています。がんの早期発見、治療効果、新しい治療法の開発における画像技術の利用は着実に拡大しており、がんの臨床管理に大きな影響を与えています。したがって、早期診断に対する意識の高まりは、陽電子放射断層撮影（PET）、単光子放射コンピュータ断層撮影（SPECT）、陽電子放射断層撮影-コンピュータ断層撮影（PET-CT）、単光子放射コンピュータ断層撮影-コンピュータ断層撮影（SPECT-CT）などの診断製品に対する需要を押し上げる可能性が高いです。このことが、世界の分子イメージング市場の成長を促進すると期待されています。さらに、技術的に先進的な製品の採用が急増していることも市場成長の原動力になると予想されます。例えば、2021年6月、画像診断システムの大手プロバイダーであるCanon Medical Systems USA Inc.は、Cartesion PrimeデジタルPET/CTシステムに採用されているディープラーニング再構成（DLR）技術とAdvanced intelligent Clear-IQ Engine（AiCE）が米国食品医薬品局（FDA）から510（k）認可を取得しました。AiCEを搭載したCartesion Primeは、臨床医が一貫して高品質な画像を日常的に作成できるよう支援します。

当レポートの主な特徴

当レポートは、世界の分子イメージング市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界の分子イメージング市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
「世界の分子イメージング市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
利害関係者は、世界の分子イメージング市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

企業プロファイル
- GE Healthcare
- Bruker Corporation
- Fujifilm Holdings Corp.
- Siemens Healthineers
- Koninklijke Philips NV
- Canon Medical Systems Corporation
- United Imaging Healthcare Co., Ltd.
- Mediso Kft.
- Positron Corporation
- Esaote SpA
- Carestream Health
- Mirada Medical Limited
- Hermes Medical Solutions

第10章セクション

参考文献
分析手法

Product Code: CMI2191

Global molecular imaging market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 7.79 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.32 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 7.79 Bn

Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.

Market Dynamics

Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.

Key features of the study:

This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global molecular imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.

Market Segmentation

Global Molecular Imaging Market, By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography- Computed Tomography (PET-CT)
- Positron Emission Tomography- Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
Global Molecular Imaging Market, By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
Global Molecular Imaging Market, By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
Global Molecular Imaging Market, By Region:
- North America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- U.S.
- Canada
- Latin America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- GE Healthcare
- Bruker Corporation
- Fujifilm Holdings Corp.
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
- Mediso kft.
- Positron Corporation
- ESAOTE S.P.A.
- Carestream Health
- Mirada Medical Limited
- Hermes Medical Solutions

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Molecular Imaging Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - Molecular Ultrasound Imaging
  - Positron Emission Tomography (PET)
  - Single Photon Emission Computed Tomography (SPECT)
  - Nuclear Magnetic Resonance (NMR) Spectrometer
  - Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT)
  - Positron Emission Tomography- Magnetic Resonance (PET-MR)
  - Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  - Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR))
Software Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - On Premises Solutions
  - Cloud Based Solutions

6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Others

8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Region/Country, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GE Healthcare
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bruker Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fujifilm Holdings Corp.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Siemens Healthineers
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Koninklijke Philips N.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Canon Medical Systems Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- United Imaging Healthcare Co., Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mediso Kft.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Positron Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Esaote SpA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Carestream Health
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mirada Medical Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hermes Medical Solutions
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact

分子イメージング市場：製品種類別、ソフトウェアプラットフォーム別、用途別、エンドユーザー別、地域別

Molecular Imaging Market, By Product Type, Software Platforms, By Application, By End User, By Geography

市場力学

当レポートの主な特徴

目次

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向の分析

第4章世界の分子イメージング市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

第5章世界の分子イメージング市場：製品種類別（2020～2032年）

第6章世界の分子イメージング市場：用途別（2020～2032年）

第7章世界の分子イメージング市場：エンドユーザー別（2020～2032年）

第8章世界の分子イメージング市場：地域別（2020～2032年）

第9章競合情勢

第10章セクション

Market Dynamics

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Molecular Imaging Market - COVID-19 Impact Analysis

5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)

6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)

7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)

8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)

9. Competitive Landscape

10. Section

分子イメージング市場：製品種類別、ソフトウェアプラットフォーム別、用途別、エンドユーザー別、地域別

Molecular Imaging Market, By Product Type, Software Platforms, By Application, By End User, By Geography

市場力学

当レポートの主な特徴

目次

第1章 分析目的と前提条件

第2章 市場の展望

第3章 市場力学・規制・動向の分析

第4章 世界の分子イメージング市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

第5章 世界の分子イメージング市場：製品種類別（2020～2032年）

第6章 世界の分子イメージング市場：用途別（2020～2032年）

第7章 世界の分子イメージング市場：エンドユーザー別（2020～2032年）

第8章 世界の分子イメージング市場：地域別（2020～2032年）

第9章 競合情勢

第10章 セクション

Market Dynamics

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Molecular Imaging Market - COVID-19 Impact Analysis

5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)

6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)

7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)

8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向の分析

第4章世界の分子イメージング市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

第5章世界の分子イメージング市場：製品種類別（2020～2032年）

第6章世界の分子イメージング市場：用途別（2020～2032年）

第7章世界の分子イメージング市場：エンドユーザー別（2020～2032年）

第8章世界の分子イメージング市場：地域別（2020～2032年）

第9章競合情勢

第10章セクション